Ironwood Pharma (IRWD) Posts Narrower than Expected Q3 Loss

October 22, 2013 7:20 AM

Ironwood Pharma (NASDAQ: IRWD) reported Q3 EPS of ($0.51), $0.06 better than the analyst estimate of ($0.57). Revenue for the ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found